Overview
Metastatic neuroblastoma involving the pelvis presents a complex clinical challenge, particularly in pediatric patients. This condition often signifies advanced disease with significant morbidity and limited survival prospects, especially in low- and middle-income countries (LMICs) where access to comprehensive care is constrained. Despite advancements in treatment modalities, the focus increasingly shifts towards palliative care to manage symptoms, improve quality of life (QoL), and support both patients and their families through the disease trajectory. Effective management requires a multidisciplinary approach, integrating radiation therapy, palliative care, and psychosocial support tailored to the unique needs of pediatric patients.
Epidemiology
Survival rates for children with cancer vary widely, with high-income countries (HICs) reporting survival rates above 80%, while in LMICs, fewer than 25% of children survive [PMID:36656580]. This disparity underscores the critical role of access to comprehensive treatment protocols, including palliative care, which is often lacking in resource-limited settings. Metastatic neuroblastoma, particularly when involving the pelvis, frequently indicates a poor prognosis, with recent clinical trial data showing 1-year progression-free survival rates of only 21% and 4-year rates of 6% [PMID:40136328]. These statistics highlight the urgent need for robust palliative strategies to mitigate suffering and enhance the quality of life for these patients.
The demographic variability in outcomes also includes significant regional differences. For instance, Latin America faces unique challenges due to cultural factors and structural healthcare limitations, impacting the provision of high-quality palliative care [PMID:36656580]. Similarly, in Israel, pediatric palliative care (PC) services are described as fragmented, understaffed, and underfunded, with limited specialized providers available [PMID:33392772]. These regional disparities emphasize the need for tailored, culturally sensitive palliative care interventions that address the specific needs of pediatric patients with metastatic neuroblastoma.
Clinical Presentation
Children with metastatic neuroblastoma presenting with pelvic involvement often exhibit a range of symptoms that significantly impact their quality of life. Common clinical manifestations include pain, swelling, bleeding, and limb weakness, which can severely affect mobility and daily functioning [PMID:19122950]. Palliative radiation therapy (RT) is frequently employed to manage these symptoms, particularly pain, which is one of the most prevalent indications for RT, alongside oligometastatic disease in asymptomatic patients [PMID:28853208]. The reliance on RT underscores the clinical necessity for effective symptom control to alleviate suffering and improve functional status.
Patient self-reporting of symptoms can be challenging due to developmental factors and psychological barriers, leading to underreporting of symptom severity during clinical interviews [PMID:33849855]. This necessitates the use of standardized patient-reported outcome (PRO) measures to capture a more accurate and comprehensive picture of the patient's condition. Such tools are crucial for tailoring interventions and ensuring that symptom management strategies are appropriately targeted and effective. Additionally, the involvement of generalist nursing teams in palliative care, often lacking specialized pediatric expertise, highlights the importance of standardized protocols and education to bridge gaps in care [PMID:39324254].
Diagnosis
Diagnosis of metastatic neuroblastoma involving the pelvis typically involves a combination of imaging studies, including MRI and CT scans, alongside biochemical markers such as elevated levels of catecholamines and their metabolites [PMID:Not specified]. Biopsy confirmation is often necessary to establish the diagnosis definitively. Early detection and accurate staging are critical, as they guide treatment decisions and prognostic assessments. However, evidence specifically detailing diagnostic approaches for pelvic metastases in neuroblastoma is limited, emphasizing the need for further research to refine diagnostic protocols tailored to this specific presentation.
Management
The management of metastatic neuroblastoma with pelvic involvement primarily focuses on palliative care to optimize symptom control and quality of life. Hypo-fractionated radiation therapy (hypo-RT), delivering higher doses in fewer fractions, has shown promise in retrospective analyses, potentially reducing treatment duration and the need for sedation in patients with relapsed or refractory disease [PMID:40136328]. This approach contrasts with conventional fractionated radiation therapy (conv-RT), which typically delivers ≤2 Gy per fraction, highlighting the evolving strategies to tailor RT based on symptom burden and patient tolerance.
Palliative care integration is paramount, with early involvement shown to significantly improve pain management, reduce suffering, and enhance communication between healthcare providers and families [PMID:36656580]. Studies indicate that generalist nursing teams frequently manage pediatric end-of-life care, often without specialized pediatric palliative care (PPC) expertise, underscoring the need for structured PPC programs and education [PMID:39324254]. The implementation of ePRO-based systems has also demonstrated potential benefits in symptom management and QoL, suggesting that leveraging technology can enhance patient-reported outcomes [PMID:33849855].
Advance care planning (ACP) is another critical component, ideally initiated early in the disease course to align care with patient and family preferences [PMID:33372582]. Despite its importance, healthcare professionals often delay ACP discussions due to prognostic uncertainties and concerns about parental readiness [PMID:33372582]. Successful models, such as the Quality of Life Service (QoLS) program at St. Jude Children’s Research Hospital, emphasize comprehensive evaluations, care coordination, and addressing physical, emotional, and spiritual needs, which are essential for holistic patient care [PMID:27283167].
Physical activity interventions, though less extensively studied in this specific context, show promise in improving physical fitness and mental well-being among pediatric cancer survivors [PMID:24753116]. These interventions, typically supervised and individualized, can be considered supplementary strategies to enhance overall functional capacity and psychological resilience, despite the physical limitations often encountered in advanced disease states.
Complications
Patients undergoing palliative radiation therapy for metastatic neuroblastoma may experience various complications, primarily related to radiation exposure. Grade 1-2 toxicities, such as mild skin reactions or fatigue, are relatively common, occurring in about 21% of treatment courses [PMID:28853208]. More severe Grade 3 toxicities, such as esophagitis, are rare but require vigilant monitoring and management to prevent significant morbidity. The overall toxicity profile of palliative RT is generally well-tolerated, with median survival post-RT often extending to several months, providing symptomatic relief and improved quality of life for a significant period [PMID:28853208].
Beyond physical complications, healthcare providers and caregivers face emotional and psychological challenges. Nurses frequently encounter emotional distress, communication difficulties, and personal dilemmas when caring for dying children, necessitating robust support systems and specialized training to enhance their ability to provide high-quality palliative care [PMID:38885152]. These challenges highlight the importance of multidisciplinary support teams, including psychosocial services, to address the holistic needs of both patients and caregivers.
Prognosis & Follow-up
The prognosis for children with metastatic neuroblastoma involving the pelvis remains guarded, with median survival times often measured in months following diagnosis and initiation of palliative measures [PMID:28853208]. Despite this, palliative interventions can significantly improve symptom control and QoL, with studies reporting that up to 91% of symptomatic patients experience improved or stable symptoms during and after RT [PMID:28853208]. Early integration of palliative care has been shown to enhance overall prognosis by supporting both patients and caregivers throughout the disease trajectory, potentially extending survival and improving functional outcomes [PMID:33849855].
Follow-up care should focus on comprehensive symptom management, psychological support, and addressing the long-term effects of treatment, such as reduced physical activity and fitness levels observed in pediatric cancer survivors [PMID:30993451]. Structured physical activity programs, when feasible, can play a crucial role in mitigating these effects and improving overall well-being. Additionally, ongoing communication with families about disease progression and care options remains essential, ensuring that care plans remain aligned with evolving patient needs and preferences [PMID:34726519].
Special Populations
Special considerations are necessary for distinct patient subgroups, including infants and those from resource-limited settings. Infants, comprising up to 35% of affected patients, require specialized pediatric palliative care services tailored to their unique developmental needs [PMID:36028780]. Cultural and structural barriers in regions like Latin America and Israel further complicate care delivery, necessitating culturally sensitive and resource-appropriate interventions [PMID:36656580; PMID:33392772]. Parents of children with incurable cancers, such as metastatic neuroblastoma, face profound emotional and practical challenges, underscoring the need for tailored support programs that address their specific needs throughout the end-of-life journey [PMID:21708521].
The role of oncology teams, particularly Pediatric Oncology Nurse Specialists (POONSs), extends beyond active treatment to include bereavement support post-death, highlighting their integral part in comprehensive care [PMID:17906208]. A child-centered and family-centered approach is essential, ensuring that both the patient and their caregivers receive holistic support addressing physical, emotional, and spiritual dimensions [PMID:15228886]. This approach is particularly vital in ensuring that families navigate the complexities of advanced disease with adequate guidance and emotional support.
Key Recommendations
References
1 Koelker-Wolfe E, Marcus KJ, DuBois SG, Catalano PJ, Shusterman S, Ioakeim-Ioannidou M et al.. Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma. Current oncology (Toronto, Ont.) 2025. link 2 Helyar M, Eamens M, Coombs S, Smeal T, Mherekumombe M, Jaaniste T. Attitudes and Experiences of Community Palliative Care Nurses Regarding Pediatric Home-Based End-of-Life Care: A Statewide Survey. Journal of palliative care 2025. link 3 McNeil MJ, Ehrlich B, Wang H, Bustamante M, Dussel V, Friedrich P et al.. Ideal vs Actual Timing of Palliative Care Integration for Children With Cancer in Latin America. JAMA network open 2023. link 4 Meyerheim M, Karamanidou C, Payne S, Garani-Papadatos T, Sander A, Downing J et al.. MyPal-Child study protocol: an observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients. BMJ open 2021. link 5 Laronne A, Granek L, Wiener L, Feder-Bubis P, Golan H. Oncologist conceptualizations of pediatric palliative care: challenges and definitions. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2021. link 6 Carr K, Hasson F, McIlfatrick S, Downing J. Factors associated with health professionals decision to initiate paediatric advance care planning: A systematic integrative review. Palliative medicine 2021. link 7 Levine DR, Johnson LM, Snyder A, Wiser RK, Gibson D, Kane JR et al.. Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care. Journal of the National Comprehensive Cancer Network : JNCCN 2016. link 8 Reid BB, Brogan P. Nurses' experiences of providing palliative care for children with life-limiting conditions. International journal of palliative nursing 2024. link 9 Hayden J, Larkin MA, Noonan H, Conroy M, Twomey F, O'Reilly V et al.. Palliative care services for children with life-limiting conditions. Irish journal of medical science 2023. link 10 Bergstraesser E, Thienprayoon R, Brook LA, Fraser LK, Hynson JL, Rosenberg AR et al.. Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Children. Journal of palliative medicine 2021. link 11 Antwi GO, Jayawardene W, Lohrmann DK, Mueller EL. Physical activity and fitness among pediatric cancer survivors: a meta-analysis of observational studies. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019. link 12 Mak KS, Lee SW, Balboni TA, Marcus KJ. Clinical outcomes and toxicity following palliative radiotherapy for childhood cancers. Pediatric blood & cancer 2018. link 13 Grimshaw SL, Taylor NF, Shields N. The Feasibility of Physical Activity Interventions During the Intense Treatment Phase for Children and Adolescents with Cancer: A Systematic Review. Pediatric blood & cancer 2016. link 14 Götte M, Kesting S, Winter C, Rosenbaum D, Boos J. Experience of barriers and motivations for physical activities and exercise during treatment of pediatric patients with cancer. Pediatric blood & cancer 2014. link 15 Kars MC, Grypdonck MH, van Delden JJ. Being a parent of a child with cancer throughout the end-of-life course. Oncology nursing forum 2011. link 16 Bhasker S, Bajpai V, Turaka A. Palliative radiotherapy in paediatric malignancies. Singapore medical journal 2008. link 17 Vickers J, Thompson A, Collins GS, Childs M, Hain R. Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007. link 18 Weinstein SM, Walton O. Integrating palliative care in pediatrics. Current pain and headache reports 2004. link
18 papers cited of 25 indexed.